Research output per year
Research output per year
Fingerprint
Dive into the research topics where Anna Maria Wiesinger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Parental perception of treatment options for mucopolysaccharidosis: a survey to bridge the gap for personalized medicine
Wiesinger, A.-M. (First author) & Lagler, F. B. (Last author), 24 Jan 2025, In: ORPHANET JOURNAL OF RARE DISEASES. 20, 1, 10 p., 36.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Development of a novel tool for individual treatment trials in mucopolysaccharidosis
Wiesinger, A.-M. (First author), Bigger, B., Giugliani, R., Lampe, C., Scarpa, M., Moser, T. (Co-author), Kampmann, C., Zimmermann, G. (Co-author) & Lagler, F. B. (Last author), 21 Nov 2024, In: JOURNAL OF INHERITED METABOLIC DISEASE . 14 p.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Development of a suspicion index tool to aid diagnosis of ASMD disease
Wiesinger, A., Lauth, W., Giugliani, R., Muschol, N., Aries, C., Moeslinger, D., Mengel, E., Weghuber, D. & Lagler, F., Feb 2024, In: MOLECULAR GENETICS AND METABOLISM . 141, 2, 2 p.Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Parental perception of treatment options for mucopolysaccharidosis: A survey to bridge the gap for personalized medicine
Wiesinger, A., Essing, M. & Lagler, F., Feb 2024, In: MOLECULAR GENETICS AND METABOLISM . 141, 2, 1 p.Research output: Contribution to journal › Abstract (Journal) › peer-review
-
Individual Treatment Trials-Do Experts Know and Use This Option to Improve the Treatability of Mucopolysaccharidosis?
Wiesinger, A. M. (First author), Strobl, H. & Lagler, F. (Last author), 9 Mar 2023, In: Pharmaceuticals (Basel, Switzerland). 16, 3, p. 416Research output: Contribution to journal › Original Article › peer-review
4 Citations (Web of Science)
Prizes
-
A Precision Medicine Tool for High Utilization and Quality of Individual Treatment Trials with Immunomodulatory Drugs in Mucopolysaccharidosis
Wiesinger, A. M. (Invited speaker)
2022Activity: Talk or presentation › Oral presentation
-
European Society for Developmental Perinatal and Paediatric Pharmacology (ESDPPP)
Wiesinger, A. M. (Membership)
2020Activity: Other scientific activities › Committee
-
European Study Group on Lysosomal Diseases (ESGLD)
Wiesinger, A. M. (Membership)
2020Activity: Other scientific activities › Committee